256 related articles for article (PubMed ID: 2943685)
1. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
[TBL] [Abstract][Full Text] [Related]
2. Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.
Strano A; Novo S; Raineri A; Alaimo G; Abrignani MG; Cutietta A
J Hypertens Suppl; 1986 Apr; 4(1):S103-6. PubMed ID: 2939208
[TBL] [Abstract][Full Text] [Related]
3. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
Novo S; Alaimo G; Giordano U; Raineri A; Strano A
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic administration of selective betablockers on peripheral circulation of the lower limbs in patients with essential hypertension.
Novo S; Pinto A; Galati D; Giannola A; Forte G; Strano A
Int Angiol; 1985; 4(2):229-34. PubMed ID: 2870124
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
[TBL] [Abstract][Full Text] [Related]
6. [Essential arterial hypertension and Leriche-Fontaine stage II obliterating vascular disease of the lower limbs. A new pharmacological approach with ketanserin].
Mollo P
Clin Ter; 1991 Apr; 137(2):113-5. PubMed ID: 1828404
[TBL] [Abstract][Full Text] [Related]
7. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
Arneklo-Nobin B; Elmér O; Akesson A
Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356
[TBL] [Abstract][Full Text] [Related]
10. Ketanserin in the treatment of mild hypertension in elderly patients: preliminary results of a controlled double-blind trial.
Dona G; Ribeiro A; Tammaro AE
J Hypertens Suppl; 1986 Apr; 4(1):S89-90. PubMed ID: 2939220
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E
Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ketanserin and pindolol in hypertension.
Gordin A; Saraste K; Turanlahti M; Sundberg S
J Hypertens Suppl; 1986 Apr; 4(1):S61-2. PubMed ID: 2939214
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
Mauersberger H
J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
[TBL] [Abstract][Full Text] [Related]
14. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
[TBL] [Abstract][Full Text] [Related]
15. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
[TBL] [Abstract][Full Text] [Related]
16. Experience with ketanserin and ritanserin in hypertensive patients.
Hedner T; Persson B
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
Klieber M; Resch F
Wien Klin Wochenschr; 1986 Feb; 98(3):70-3. PubMed ID: 2938341
[TBL] [Abstract][Full Text] [Related]
18. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
Rosenthal J; Koehle W; Gruebel B; Fisher R
J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145
[TBL] [Abstract][Full Text] [Related]
19. [Hemodynamic and humoral effects of 2 different doses of ketanserin in aged patients with hypertension].
Rizzoni D; Castellano M; Beschi M; Agabiti-Rosei E
Ann Ital Med Int; 1990; 5(4 Pt 2):489-96. PubMed ID: 2102136
[TBL] [Abstract][Full Text] [Related]
20. Lower limb haemodynamics during antihypertensive treatment with metoprolol and propranolol.
Lepäntalo MJ; Tötterman KJ
Int Angiol; 1985; 4(2):225-8. PubMed ID: 3831144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
